Drug · DIN 02548879
APIXABAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 6, 2024; first marketed November 6, 2024.
- Drug Identification Number (DIN)
- 02548879
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Apixaban B01AF02
- Class
- Human
- Record last updated
- November 25, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APIXABAN | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 18, 2024: NOC 33467Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named APIXABAN
- DIN 02530708 · Marketed
- DIN 02530716 · Marketed
- DIN 02548887 · Marketed